title: PET/CT with 18F-FLT is unlikely to cause significant hepatorenal or hematologic toxicity.
authors.forename: Malik E
authors.initials: ME
authors.lastname: Juweid
authors.forename: Damita
authors.initials: D
authors.lastname: Thomas
authors.forename: Yusuf
authors.initials: Y
authors.lastname: Menda
authors.forename: Timothy
authors.initials: T
authors.lastname: Tewson
authors.forename: Michael M
authors.initials: MM
authors.lastname: Graham
authors.forename: Ken
authors.initials: K
authors.lastname: Herrmann
authors.forename: Andreas K
authors.initials: AK
authors.lastname: Buck
authors.forename: Luis
authors.initials: L
authors.lastname: Fayad
mesh_terms: D015224:Dideoxynucleosides / Q000009:adverse effects*; D006258:Head and Neck Neoplasms / Q000000981:diagnostic imaging; D006402:Hematologic Diseases / Q000209:etiology*; D006801:Humans; D007674:Kidney Diseases / Q000209:etiology*; D008107:Liver Diseases / Q000209:etiology*; D008223:Lymphoma / Q000000981:diagnostic imaging; D049268:Positron-Emission Tomography / Q000009:adverse effects*; D011832:Radiation Injuries / Q000209:etiology*; D019275:Radiopharmaceuticals / Q000009:adverse effects*; D014055:Tomography, Emission-Computed / Q000009:adverse effects*
chemical_list: D015224:Dideoxynucleosides; D019275:Radiopharmaceuticals; C002854:alovudine